• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA RADIFOCUS GUIDEWIRE OR GLIDEWIRE OR GLIDEWIRE M; WIRE, GUIDE, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA RADIFOCUS GUIDEWIRE OR GLIDEWIRE OR GLIDEWIRE M; WIRE, GUIDE, CATHETER Back to Search Results
Model Number N/A
Medical Device Problem Codes Break (1069); Migration (4003)
Health Effect - Clinical Codes Obstruction/Occlusion (2422); Foreign Body In Patient (2687); Embolism/Embolus (4438)
Date of Event 04/07/2022
Type of Reportable Event Serious Injury
Event or Problem Description
The user facility reported that the tip of the stiff glidewire involved (3-4cm), broke off into the patient.The tip was attempted to be removed for two hours, but the tip went into a branch off the profunda and was left in the patient.The branch off was tied to ensure that the part of the wire could only go distal and not cause any harm to the patient.The doctor did not perform the endovascular iliac recanalization (evar) procedure as intended due to the wire break.The doctor had to perform a cutdown, about 6 inches on the left leg, to access the broken piece of wire.The procedure was started with left groin access via a 6 fr sheath, a 5 fr vs1 catheter, and the stiff glidewire involved in the catheter.The doctor went up and over the iliac occlusion, the doctor was burrowing the wire in the occlusion.When the doctor could not pass the occlusion, he removed the wire and noticed the tip was missing.A fluoroscopy was performed and the branch of the profunda was seen.The patient was fine.There was no atherectomy device or laser used.There was no metal introducer or dilator used.There was no excessive torque.The procedure outcome was not successful.There was no equipment or other devices used with the above product.Additional information was received on 14 apr 2022: terumo medical received a user facility medwatch report (b)(4).The event description states: "during the procedure, the wire fractured off the stiff angled glide which embolized to the left profunda.Original intended procedure was an endovascular iliac recanalization.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RADIFOCUS GUIDEWIRE OR GLIDEWIRE OR GLIDEWIRE M
Common Device Name
WIRE, GUIDE, CATHETER
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, 418
JA  418
MDR Report Key14192637
Report Number2243441-2022-00015
Device Sequence Number4446865
Product Code DQX
UDI-Device Identifier04987350773654
UDI-Public04987350773654
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Importer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 04/25/2022
Report Date (Section F) 04/25/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/31/2023
Device Model NumberN/A
Device Catalogue NumberGS3509
Device Lot Number210914
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date04/07/2022
Device Age7 MO
Event Location Hospital
Date Report to Manufacturer04/08/2022
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date04/25/2022
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
5 FR VS1 CATHETER
Outcome Attributed to Adverse Event Required Intervention; Other;
Patient Age73 YR
Patient SexMale
Date Report Sent to FDA04/25/2022
-
-